Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Kastrati, F. Neumann, J. Mehilli, R. Byrne, R. Iijima, H. Büttner, A. Khattab, S. Schulz, J. Blankenship, J. Pache, J. Minners, M. Seyfarth, Isolde Graf, K. Skelding, J. Dirschinger, G. Richardt, P. Berger, A. Schömig (2008)
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.The New England journal of medicine, 359 7
M. Pfisterer (2004)
Long-Term Outcome in Elderly Patients With Chronic Angina Managed Invasively Versus by Optimized Medical Therapy: Four-Year Follow-Up of the Randomized Trial of Invasive Versus Medical Therapy in Elderly Patients (TIME)Circulation, 110
W. Weintraub, E. Veledar, T. Thompson, J. Burnette, C. Jurkovitz, E. Mahoney (2001)
Percutaneous coronary intervention outcomes in octogenarians during the stent era (National Cardiovascular Network).The American journal of cardiology, 88 12
Leonid Yatskar, F. Selzer, F. Feit, H. Cohen, A. Jacobs, David Williams, J. Slater (2007)
Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: Data from the National Heart, Lung, and Blood Institute Dynamic RegistryCatheterization and Cardiovascular Interventions, 69
D. Feldman, C. Gade, Alexander Slotwiner, M. Parikh, G. Bergman, S. Wong, Robert Minutello (2006)
Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).The American journal of cardiology, 98 10
The Investigators (2001)
Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trialThe Lancet, 358
G. Stone, B. Witzenbichler, G. Guagliumi, J. Peruga, B. Brodie, Dariusz Dudek, Ran Kornowski, Franz Hartmann, B. Gersh, S. Pocock, G. Dangas, S. Wong, Ajay Kirtane, H. Parise, R. Mehran (2008)
Bivalirudin during primary PCI in acute myocardial infarction.The New England journal of medicine, 358 21
P. Wenaweser, M. Ramser, S. Windecker, I. Lütolf, B. Meier, C. Seiler, Franz Eberli, O. Hess (2007)
Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 70 4
Salah-Eddine Hassani, R. Wolfram, P. Kuchulakanti, Zhenyi Xue, N. Gevorkian, W. Suddath, L. Satler, K. Kent, A. Pichard, N. Weissman, R. Waksman (2006)
Percutaneous coronary intervention with drug‐eluting stents in octogenarians: Characteristics, clinical presentation, and outcomesCatheterization and Cardiovascular Interventions, 68
G. Stone, H. White, E. Ohman, M. Bertrand, A. Lincoff, B. McLaurin, D. Cox, S. Pocock, J. Ware, F. Feit, A. Colombo, S. Manoukian, A. Lansky, R. Mehran, J. Moses (2007)
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialThe Lancet, 369
J. Chesebro, G. Knatterud, R. Roberts, J. Borer, L. Cohen, J. Dalen, H. Dodge, C. Francis, D. Hillis, P. Ludbrook (1987)
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 76 1
T. Kinnaird, E. Stabile, G. Mintz, Cheol-Whan Lee, D. Canos, N. Gevorkian, E. Pinnow, K. Kent, A. Pichard, L. Satler, N. Weissman, J. Lindsay, S. Fuchs (2003)
Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.The American journal of cardiology, 92 8
Michael Lee, R. Zimmer, Antonio Pessegueiro, Daniel Jurewitz, J. Tobis (2008)
Outcomes of nonagenarians who undergo percutaneous coronary intervention with drug‐eluting stentsCatheterization and Cardiovascular Interventions, 71
T. Bauer, O. Koeth, C. Jünger, T. Heer, H. Wienbergen, A. Gitt, R. Zahn, J. Senges, U. Zeymer (2007)
Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction.European heart journal, 28 23
B. Yan, R. Gurvitch, S. Duffy, D. Clark, M. Sebastian, G. New, R. Warren, J. Lefkovits, R. Lew, A. Brennan, C. Reid, N. Andrianopoulos, A. Ajani (2007)
An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registryCatheterization and Cardiovascular Interventions, 70
Sidney Smith, T. Feldman, J. Hirshfeld, A. Jacobs, M. Kern, S. King, D. Morrison, W. O’Neill, H. Schaff, P. Whitlow, David Williams, E. Antman, Sidney Smith, C. Adams, Jeffrey Anderson, D. Faxon, V. Fuster, J. Halperin, L. Hiratzka, S. Hunt, Rick Nishimura, J. Ornato, R. Page, B. Riegel (2006)
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary InterventionCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 67 1
S. Manoukian, F. Feit, R. Mehran, Michele Voeltz, R. Ebrahimi, M. Hamon, G. Dangas, A. Lincoff, H. White, J. Moses, S. King, E. Ohman, G. Stone (2007)
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.Journal of the American College of Cardiology, 49 12
R. Moreno, A. Salazar, C. Bañuelos, R. Hernández, F. Alfonso, M. Sabaté, J. Escaned, Maria-José Perez, L. Azcona, C. Macaya (2004)
Effectiveness of percutaneous coronary interventions in nonagenarians.The American journal of cardiology, 94 8
Sidney Smith, T. Feldman, J. Hirshfeld, A. Jacobs, M. Kern, S. King, D. Morrison, W. O’Neill, H. Schaff, P. Whitlow, David Williams, E. Antman, C. Adams, Jeffrey Anderson, D. Faxon, V. Fuster, J. Halperin, L. Hiratzka, S. Hunt, Rick Nishimura, J. Ornato, R. Page, B. Riegel (2006)
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary InterventionCirculation, 113 1
R. Myler, R. Shaw, S. Stertzer, H. Hecht, C. Ryan, J. Rosenblum, D. Cumberland, M. Murphy, Hansell Hn, Benito Hidalgo (1992)
Lesion morphology and coronary angioplasty: current experience and analysis.Journal of the American College of Cardiology, 19 7
Yoshio Kobayashi, R. Mehran, G. Mintz, G. Dangas, I. Moussa, A. Lansky, G. Stone, J. Moses, M. Leon (2003)
Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old.The American journal of cardiology, 92 4
P. Vlaar, R. Lennon, C. Rihal, Mandeep Singh, H. Ting, J. Bresnahan, D. Holmes (2008)
Drug-eluting stents in octogenarians: early and intermediate outcome.American heart journal, 155 4
W. Batchelor, K. Anstrom, L. Muhlbaier, R. Grosswald, W. Weintraub, W. O’Neill, E. Peterson (2000)
Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration.Journal of the American College of Cardiology, 36 3
I. Teplitsky, A. Assali, E. Lev, D. Brosh, H. Vaknin-Assa, R. Kornowski (2007)
Results of percutaneous coronary interventions in patients ≥90 years of ageCatheterization and Cardiovascular Interventions, 70
F. Feit, Michele Voeltz, M. Attubato, A. Lincoff, Derek Chew, J. Bittl, E. Topol, S. Manoukian (2007)
Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial.The American journal of cardiology, 100 9
Michele Voeltz, Amar Patel, F. Feit, R. Fazel, A. Lincoff, S. Manoukian (2007)
Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention.The American journal of cardiology, 99 11
L. Dacey, D. Likosky, T. Ryan, J. Robb, R. Quinn, James DeVries, M. Hearne, B. Leavitt, R. Dunton, R. Clough, D. Sisto, C. Ross, E. Olmstead, G. O'connor, D. Malenka (2007)
Long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease.The Annals of thoracic surgery, 84 6
Abid Assali, A. Moustapha, S. Sdringola, J. Salloum, H. Awadalla, Sangeeta Saikia, Mohammad Ghani, S. Hale, G. Schroth, O. Rosales, H. Anderson, R. Smalling (2003)
The dilemma of success: Percutaneous coronary interventions in patients ≥ 75 years of age—successful but associated with higher vascular complications and cardiac mortalityCatheterization and Cardiovascular Interventions, 59
T. Little, M. Milner, K. Lee, J. Constantine, A. Pichard, J. Lindsay (1993)
Late outcome and quality of life following percutaneous transluminal coronary angioplasty in octogenarians.Catheterization and cardiovascular diagnosis, 29 4
Background: With an aging population, nonagenarians constitute an increasing percentage of patients with coronary artery disease. The aim of this study was to determine the predictors and outcome of nonagenarians undergoing percutaneous coronary intervention (PCI) for symptomatic coronary artery disease. Methods: From 2002 to 2007, a cohort of 171 consecutive nonagenarians underwent PCI and stent implantation in our center. Patients given bivalirudin (n = 79) during the procedure were compared to those given heparin (n = 92). In‐hospital and 6‐month rates of major adverse cardiovascular events (MACE) including death, myocardial infarction (MI), and target lesion revascularization were indexed. In‐hospital bleedings were also indexed. Results: The mean age was 92.5 ± 2.5 years. The population was 52% female. Nearly 30% of patients had diabetes mellitus and >25% had renal failure. The mean left ventricular ejection fraction was 45%± 14%. The clinical presentation was an acute MI in 59% of the cases. The in‐hospital rates of death and bleedings were 4.1% and 17.5%, respectively. Clinical presentations as MI or cardiogenic shock were associated with high rates of in‐hospital death: 19.3% and 30%, respectively. Bivalirudin use was associated with a 41.5% decrease in in‐hospital bleedings. The 6‐month incidence of MACE was 13.6% and was driven by death. Predictors of 6‐month outcomes were clinical presentations as MI or cardiogenic shock, renal failure, and total stent length. Conclusion: Nonagenarians represent a particular population with a high percentage of females and a high incidence of comorbidities. In this study, we highlighted that nonagenarians have logically a worse prognosis than is reported in younger patients, with especially high rates of in‐hospital bleedings. Bivalirudin use was associated with an important decrease in in‐hospital bleedings; thus, it should be systematically considered in such patients to improve early outcome.
Journal of Interventional Cardiology – Wiley
Published: Feb 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.